363 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
AASS Aminoadipate-semialdehyde synthase
Vesicles Liver cancer: 9.81e-4 Mixed
ACADL Acyl-CoA dehydrogenase, long chain
Renal cancer: 1.58e-11 Tissue enhanced thyroid gland: 31.9
ACADM Acyl-CoA dehydrogenase, C-4 to C-12 straight chain
Mitochondria Renal cancer: 3.83e-8 Colorectal cancer: 7.30e-4 Expressed in all
ACADS Acyl-CoA dehydrogenase, C-2 to C-3 short chain
Nucleoplasm Renal cancer: 3.33e-6 Urothelial cancer: 6.34e-5 Liver cancer: 2.43e-4 Endometrial cancer: 5.05e-4 Glioma: 9.94e-4 Expressed in all
ACADSB Acyl-CoA dehydrogenase, short/branched chain
Mitochondria Renal cancer: 6.37e-12 Pancreatic cancer: 3.40e-4 Expressed in all
ACADVL Acyl-CoA dehydrogenase, very long chain
Nucleus Pancreatic cancer: 6.87e-4 Expressed in all
ACOX1 Acyl-CoA oxidase 1, palmitoyl
Nucleus Renal cancer: 5.25e-7 Expressed in all
ACOX2 Acyl-CoA oxidase 2, branched chain
Vesicles Tissue enhanced liver: 87.8
ACOX3 Acyl-CoA oxidase 3, pristanoyl
Peroxisomes Endometrial cancer: 2.16e-4 Expressed in all
ADH1A Alcohol dehydrogenase 1A (class I), alpha polypeptide
Plasma membrane Liver cancer: 2.38e-4 Tissue enriched 134 liver: 1364.4
ADH1B Alcohol dehydrogenase 1B (class I), beta polypeptide
Plasma membrane Renal cancer: 7.87e-4 Group enriched 6 adipose tissue: 1534.1 liver: 2889.4
ADH1C Alcohol dehydrogenase 1C (class I), gamma polypeptide
Nucleoplasm Lung cancer: 2.99e-4 Liver cancer: 4.55e-4 Tissue enhanced duodenum: 522.4 liver: 886.9 stomach: 478.6
ADH4 Alcohol dehydrogenase 4 (class II), pi polypeptide
Nucleus Liver cancer: 7.08e-6 Tissue enriched 15 liver: 2627.7
ADH5 Alcohol dehydrogenase 5 (class III), chi polypeptide
Renal cancer: 4.58e-10 Endometrial cancer: 9.90e-5 Melanoma: 3.54e-4 Expressed in all
ADH7 Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
Plasma membrane Tissue enriched 6 esophagus: 216.3
ADHFE1 Alcohol dehydrogenase, iron containing, 1
Vesicles Renal cancer: 4.55e-5 Breast cancer: 5.76e-5 Liver cancer: 9.90e-5 Mixed
ADI1 Acireductone dioxygenase 1
Nucleoplasm Expressed in all
ADO 2-aminoethanethiol (cysteamine) dioxygenase
Liver cancer: 8.01e-5 Expressed in all
AGMO Alkylglycerol monooxygenase
Vesicles Tissue enhanced liver: 63.6
AKR1A1 Aldo-keto reductase family 1, member A1 (aldehyde reductase)
Nucleoplasm Cervical cancer: 2.66e-6 Endometrial cancer: 2.92e-4 Expressed in all
AKR1B1 Aldo-keto reductase family 1, member B1 (aldose reductase)
Nucleus Stomach cancer: 2.44e-5 Urothelial cancer: 7.00e-4 Tissue enriched 6 adrenal gland: 2498.2
AKR1B15 Aldo-keto reductase family 1, member B15 N/A
Plasma membrane Liver cancer: 1.80e-5 Urothelial cancer: 1.90e-5 Head and neck cancer: 8.36e-4 Tissue enriched 12 breast: 176.5
AKR1C1 Aldo-keto reductase family 1, member C1
Endoplasmic reticulum Renal cancer: 8.03e-9 Liver cancer: 1.56e-4 Cervical cancer: 3.05e-4 Expressed in all
AKR1C2 Aldo-keto reductase family 1, member C2
Nucleus Group enriched 5 adipose tissue: 352.3 breast: 122.0 esophagus: 118.4 gallbladder: 189.9 liver: 186.5 stomach: 138.5 urinary bladder: 186.3
AKR1C3 Aldo-keto reductase family 1, member C3
Nucleus Renal cancer: 1.22e-4 Liver cancer: 1.96e-4 Expressed in all
AKR1C4 Aldo-keto reductase family 1, member C4
Nucleus Tissue enriched 6 liver: 358.9
AKR1D1 Aldo-keto reductase family 1, member D1
Nucleoplasm Liver cancer: 9.91e-5 Tissue enriched 32 liver: 229.0
AKR1E2 Aldo-keto reductase family 1, member E2
Nucleoplasm Tissue enhanced testis: 30.0
AKR7A2 Aldo-keto reductase family 7, member A2
Cytosol Renal cancer: 2.67e-4 Urothelial cancer: 8.59e-4 Expressed in all
ALDH18A1 Aldehyde dehydrogenase 18 family, member A1
Mitochondria Renal cancer: 3.60e-9 Endometrial cancer: 4.20e-4 Expressed in all
ALDH1A1 Aldehyde dehydrogenase 1 family, member A1
Cytosol Cervical cancer: 7.77e-5 Expressed in all
ALDH1A2 Aldehyde dehydrogenase 1 family, member A2
Tissue enhanced endometrium: 117.2 fallopian tube: 107.1
ALDH1A3 Aldehyde dehydrogenase 1 family, member A3
Nucleus Tissue enhanced prostate: 209.6
ALDH1B1 Aldehyde dehydrogenase 1 family, member B1
Nucleoplasm Thyroid cancer: 1.17e-5 Renal cancer: 2.05e-4 Expressed in all
ALDH1L1 Aldehyde dehydrogenase 1 family, member L1
Cytosol Renal cancer: 2.42e-8 Tissue enhanced kidney: 123.5 liver: 191.5
ALDH1L2 Aldehyde dehydrogenase 1 family, member L2 N/A
Mitochondria Mixed
ALDH2 Aldehyde dehydrogenase 2 family (mitochondrial)
Liver cancer: 3.95e-7 Renal cancer: 5.24e-6 Endometrial cancer: 2.63e-4 Urothelial cancer: 7.71e-4 Expressed in all
ALDH3A1 Aldehyde dehydrogenase 3 family, member A1
Vesicles Head and neck cancer: 7.55e-5 Group enriched 7 esophagus: 407.6 skin: 84.5 stomach: 210.9
ALDH3A2 Aldehyde dehydrogenase 3 family, member A2
Renal cancer: 3.85e-8 Expressed in all
ALDH3B1 Aldehyde dehydrogenase 3 family, member B1
Colorectal cancer: 1.18e-4 Pancreatic cancer: 6.07e-4 Tissue enhanced fallopian tube: 63.7 lung: 67.9
ALDH3B2 Aldehyde dehydrogenase 3 family, member B2
Group enriched 5 breast: 88.2 esophagus: 103.8 skin: 122.4
ALDH4A1 Aldehyde dehydrogenase 4 family, member A1
Cervical cancer: 5.06e-4 Tissue enhanced kidney: 184.9 liver: 108.1
ALDH5A1 Aldehyde dehydrogenase 5 family, member A1
Mitochondria Liver cancer: 7.61e-6 Renal cancer: 3.68e-4 Ovarian cancer: 6.20e-4 Expressed in all
ALDH6A1 Aldehyde dehydrogenase 6 family, member A1
Mitochondria Renal cancer: 2.00e-15 Lung cancer: 4.22e-4 Expressed in all
ALDH7A1 Aldehyde dehydrogenase 7 family, member A1
Mitochondria Renal cancer: 3.08e-4 Expressed in all
ALDH9A1 Aldehyde dehydrogenase 9 family, member A1
Cytosol Pancreatic cancer: 4.56e-4 Expressed in all
ALKBH1 AlkB homolog 1, histone H2A dioxygenase
Renal cancer: 1.80e-4 Mixed
ALKBH2 AlkB homolog 2, alpha-ketoglutarate-dependent dioxygenase
Nucleus Renal cancer: 1.41e-5 Breast cancer: 6.67e-5 Urothelial cancer: 8.67e-4 Expressed in all
ALOX12 Arachidonate 12-lipoxygenase
Nuclear speckles Group enriched 5 esophagus: 50.5 skin: 26.0
ALOX15 Arachidonate 15-lipoxygenase
Tissue enhanced fallopian tube: 19.3 lung: 9.9
Page next »
